Background: Nucleoside reverse transcriptase inhibitors (NRTIs) are the cornerstone of the
antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency …

Neuropathic pain associated with nucleoside reverse transcriptase inhibitors (NRTIs),
therapeutic agents for human immunodeficiency virus (HIV), responds poorly to available …

Human immunodeficiency virus (HIV) infection and antiretroviral therapy can independently
induce HIV-associated neuropathic pain (HIV-NP). There is a dearth of drugs or therapeutic …

The most common neurological complication in patients receiving successful combination
antiretroviral therapy (cART) is peripheral neuropathic pain. Data show that distal symmetric …

Although antiretroviral agents have been used successfully in suppressing viral production,
they have also been associated with a number of side effects. The antiretroviral toxic …

Painful peripheral neuropathy is a common neurological complication associated with
human immunodeficiency virus (HIV) infection and anti-retroviral therapy. We characterized …

Neuropathic pain sometimes occurs during chemotherapy with paclitaxel or HIV/AIDS
antiretroviral therapy with nucleoside reverse transcriptase inhibitors (NRTIs). We previously …

A major dose‐limiting side effect of human immunodeficiency virus/acquired
immunodeficiency syndrome (HIV/AIDS) chemotherapies, such as the nucleoside reverse …

Chemotherapy-induced neuropathic pain is a serious clinical problem and one of the major
side effects in cancer treatment. The endocannabinoid system (ECS) plays a crucial role in …

BACKGROUND Background: Painful peripheral neuropathy continues to be a significant
clinical problem in patients (pts) with HIV infection. Preclinical studies suggest that …